Listing Details

  • Listed on National Stock Exchange of India (NSE) and BSE Limited on November 4, 2026
  • Company is a demerged division of India Glycols Limited
  • Regulatory reference: Regulation 30 of SEBI Listing Regulations

Financial Performance (FY26)

  • Biopharma division reported net revenue: ₹246 crore
  • EBITDA: ₹29 crore
  • Gross margin: 40.1%

Business Segments Breakdown

API Business (67% of sales)

  • Products: thiocolchicoside, colchicine, nicotine, vinpocetine
  • Customer base: Over 150 active customers across 26+ countries
  • Export contribution: 54% of segment revenues in FY26
  • Business established over 15 years

Biopolymer Operations (16% of sales)

  • Products: guar gum and specialty gums
  • End markets: oil and gas, food and beverages, personal care, paints, textiles, supplements
  • Export contribution: 69% of FY26 revenues
  • Customer base: Across 23 countries

Nutraceuticals (17% of sales)

  • Flagship brands: Aspargize, Gingeren, Maxicuma®, Xanthogreen®, Berbisol™
  • Market segments: women's health, bone and joint health, eye health, metabolic health
  • Customer base: Over 90 active customers across 19+ countries
  • Export contribution: 83% of revenues in FY26

Growth Strategy

  • Introduce one new API annually
  • Expand presence in regulated markets
  • Strengthen nicotine replacement therapy portfolio
  • Develop specialized derivatives in biopolymers
  • Expand dietary fiber applications
  • Increase contribution of higher-value products
  • Expand branded nutraceutical portfolio to 6-8 ingredients
  • Strengthen distribution across US, Europe, and Asia
  • Deepen relationships with leading nutraceutical customers

Technology and Research

  • Proprietary platforms: LIMAN™ and SCEMOD™ (focus on improving solubility and bio-absorption)
  • Patent portfolio: 9 patents filed, 5 granted patents, 4 patents under review
  • Research program: 20 clinical trials
  • International presence: Local US office supporting customer coverage and stocking capabilities

Manufacturing Capabilities

  • Dehradun facility: 1,600 metric tonnes capacity
  • Kashipur facility: 24,000 metric tonnes capacity
  • Technologies: Supercritical fluid extraction, solvent and aqueous extraction, bio-fermentation, semi-formulation
  • Quality certifications: EU-GMP, CEP's, USFDA, NSF-GMP